Clinical Trial Update: Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial tested total-body irradiation with thiotepa and fludarabine as conditioning before donor stem cell transplant in young patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Fludarabine (Fludarabine)
• THIOTEPA (THIOTEPA)
• Total Body Irradiation

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED